Results 251 to 260 of about 733,442 (314)
The Top 100 Most Cited Articles on Epilepsy Surgery: A Bibliometric Analysis of the Literature. [PDF]
Gould J, Patel S, Chaurasia B.
europepmc +1 more source
Brain network analysis of patients with Temporal Lobe Epilepsy
Alia Lemkaddem +7 more
openalex +1 more source
Noninvasive Imaging of the High Frequency Brain Activity in Focal Epilepsy Patients
Yunfeng Lu +6 more
openalex +2 more sources
Turning Slowly Predicts Future Diagnosis of Parkinson's Disease: A Decade‐Long Longitudinal Analysis
Objective Wearable technology allows accurate measurement of turning while walking, with cross‐sectional studies indicating that difficulty turning presents even in preclinical phases of Parkinson's disease. The aim of our study was to quantify rate of change of turning performance in a cohort of older adults, and test whether turning decline can ...
Morad Elshehabi +9 more
wiley +1 more source
Interictal Psychosis-A New Reason to Conduct Epilepsy Gene Testing? [PDF]
Munger Clary HM.
europepmc +1 more source
Pro‐Inflammatory c‐Met+ CD4 T Cells in Multiple Sclerosis
Objective Hepatocyte growth factor (HGF) binds exclusively the c‐Met surface receptor, and the HGF/c‐Met axis regulates T cell function in autoimmune diseases. We analyzed c‐Met expression on human CD4 T cells in the blood and cerebrospinal fluid (CSF) from patients with multiple sclerosis (MS) versus non‐inflammatory neurological disease (NIND), to ...
Gautier Breville +6 more
wiley +1 more source
<i>Lachnospira eligens</i> attenuates epileptogenesis via gut-brain axis regulation of blood-brain barrier integrity and neuroinflammation. [PDF]
Li H +11 more
europepmc +1 more source
Back Again to the Future: A New Era for Cerebroprotection
Cerebroprotection is a fresh framework for designing neurological therapy that targets glia and vascular cells, in addition to neurons. In the future, successful cerebroprotection will involve targeting all elements of the neurovascular unit. Preclinical trials must include functional outcomes, as well as lesion morphometry.
Patrick Lyden
wiley +1 more source

